Format

Send to

Choose Destination
Lancet Oncol. 2019 Apr;20(4):e191. doi: 10.1016/S1470-2045(19)30165-2.

Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein.

Author information

1
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. Electronic address: azhu@mgh.harvard.edu.
2
Geffen School of Medicine, University of California, Los Angeles, CA, USA.
3
University Medical Center, Mainz, Germany.
4
Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institut d'Investigations Biomèdiques August Pi i Sunyer, Hospital Clinic Barcelona, Barcelona, Spain.
5
Kindai University, Osaka-Sayama, Japan.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center